Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2021-07, Vol.144 (3), p.e38-e39
Main Authors: Singh, Jagdeep S., Struthers, Allan D., Lang, Chim C.
Format: Article
Language:English
Subjects:
Benzhydryl Compounds - adverse effects
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucosides
Heart Failure - diagnosis
Heart Failure - drug therapy
Humans
Prediabetic State
Stroke Volume
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3
cites cdi_FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3
container_end_page e39
container_issue 3
container_start_page e38
container_title Circulation (New York, N.Y.)
container_volume 144
creator Singh, Jagdeep S.
Struthers, Allan D.
Lang, Chim C.
description
doi_str_mv 10.1161/CIRCULATIONAHA.120.053057
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1161_CIRCULATIONAHA_120_053057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34279989</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3</originalsourceid><addsrcrecordid>eNpVkc1u00AQx1cIREPhFdBwo1KdznrtbHy00qSJFNoqTcrRWtvjZMvGjtZrVeHUB4Gn4g36JCwyVOI0n_-Z0fwY-8RxyPmIX0wWq8lmma4XN9fpPB3yEIcYC4zlKzbgcRgFUSyS12yAiEkgRRiesHdt--DDkZDxW3YiolAmyTgZsF9Lco4s5Ee40_V2B-RAGVjRVtnSJyC1TheGzuH56ce0qqhw0FQw3R_U1ujKNN91DU0NS6oc3FPtrC46oyzcN6bbUwu-fKuc9pUWvmq3g_XxQBDCpVY5OWrPobFwa6l8iVVdwpyUdTBT2nSWet2Kyq6gEqYP_gbtV86s6p3Pd5urdBVcfgnms7Pnp5_v2ZtKmZY-_LWnbDObrifzYHlztZiky6CIuMBAYkkqT-JIxUKqBCkpc06oKB_lHOWYV8QR48S_VnIpizFyzKu4FFSV4xEV4pQl_dzCNm1rqcoOVu-VPWYcsz-gsv9BZR5U1oPy2o-99tDleypflP_I-Iaob3hsjAfUfjPdI9lsR8q4XeZRokAugxBDf2uIGPgMR_EbA72jIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”</title><source>Free E-Journal (出版社公開部分のみ）</source><creator>Singh, Jagdeep S. ; Struthers, Allan D. ; Lang, Chim C.</creator><creatorcontrib>Singh, Jagdeep S. ; Struthers, Allan D. ; Lang, Chim C.</creatorcontrib><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.120.053057</identifier><identifier>PMID: 34279989</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Benzhydryl Compounds - adverse effects ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Glucosides ; Heart Failure - diagnosis ; Heart Failure - drug therapy ; Humans ; Prediabetic State ; Stroke Volume</subject><ispartof>Circulation (New York, N.Y.), 2021-07, Vol.144 (3), p.e38-e39</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3</citedby><cites>FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3</cites><orcidid>0000-0002-7358-9712 ; 0000-0002-4530-3078</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34279989$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Jagdeep S.</creatorcontrib><creatorcontrib>Struthers, Allan D.</creatorcontrib><creatorcontrib>Lang, Chim C.</creatorcontrib><title>Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Benzhydryl Compounds - adverse effects</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Glucosides</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - drug therapy</subject><subject>Humans</subject><subject>Prediabetic State</subject><subject>Stroke Volume</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkc1u00AQx1cIREPhFdBwo1KdznrtbHy00qSJFNoqTcrRWtvjZMvGjtZrVeHUB4Gn4g36JCwyVOI0n_-Z0fwY-8RxyPmIX0wWq8lmma4XN9fpPB3yEIcYC4zlKzbgcRgFUSyS12yAiEkgRRiesHdt--DDkZDxW3YiolAmyTgZsF9Lco4s5Ee40_V2B-RAGVjRVtnSJyC1TheGzuH56ce0qqhw0FQw3R_U1ujKNN91DU0NS6oc3FPtrC46oyzcN6bbUwu-fKuc9pUWvmq3g_XxQBDCpVY5OWrPobFwa6l8iVVdwpyUdTBT2nSWet2Kyq6gEqYP_gbtV86s6p3Pd5urdBVcfgnms7Pnp5_v2ZtKmZY-_LWnbDObrifzYHlztZiky6CIuMBAYkkqT-JIxUKqBCkpc06oKB_lHOWYV8QR48S_VnIpizFyzKu4FFSV4xEV4pQl_dzCNm1rqcoOVu-VPWYcsz-gsv9BZR5U1oPy2o-99tDleypflP_I-Iaob3hsjAfUfjPdI9lsR8q4XeZRokAugxBDf2uIGPgMR_EbA72jIQ</recordid><startdate>20210720</startdate><enddate>20210720</enddate><creator>Singh, Jagdeep S.</creator><creator>Struthers, Allan D.</creator><creator>Lang, Chim C.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7358-9712</orcidid><orcidid>https://orcid.org/0000-0002-4530-3078</orcidid></search><sort><creationdate>20210720</creationdate><title>Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”</title><author>Singh, Jagdeep S. ; Struthers, Allan D. ; Lang, Chim C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Benzhydryl Compounds - adverse effects</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Glucosides</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - drug therapy</topic><topic>Humans</topic><topic>Prediabetic State</topic><topic>Stroke Volume</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Jagdeep S.</creatorcontrib><creatorcontrib>Struthers, Allan D.</creatorcontrib><creatorcontrib>Lang, Chim C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Jagdeep S.</au><au>Struthers, Allan D.</au><au>Lang, Chim C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2021-07-20</date><risdate>2021</risdate><volume>144</volume><issue>3</issue><spage>e38</spage><epage>e39</epage><pages>e38-e39</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>34279989</pmid><doi>10.1161/CIRCULATIONAHA.120.053057</doi><orcidid>https://orcid.org/0000-0002-7358-9712</orcidid><orcidid>https://orcid.org/0000-0002-4530-3078</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2021-07, Vol.144 (3), p.e38-e39
issn 0009-7322
1524-4539
language eng
recordid cdi_crossref_primary_10_1161_CIRCULATIONAHA_120_053057
source Free E-Journal (出版社公開部分のみ）
subjects Benzhydryl Compounds - adverse effects
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucosides
Heart Failure - diagnosis
Heart Failure - drug therapy
Humans
Prediabetic State
Stroke Volume
title Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A24%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20by%20Singh%20et%20al%20Regarding%20Article,%20%E2%80%9CEffect%20of%20Empagliflozin%20on%20Left%20Ventricular%20Volumes%20in%20Patients%20With%20Type%202%20Diabetes,%20or%20Prediabetes,%20and%20Heart%20Failure%20With%20Reduced%20Ejection%20Fraction%20(SUGAR-DM-HF)%E2%80%9D&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Singh,%20Jagdeep%20S.&rft.date=2021-07-20&rft.volume=144&rft.issue=3&rft.spage=e38&rft.epage=e39&rft.pages=e38-e39&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.120.053057&rft_dat=%3Cpubmed_cross%3E34279989%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4130-70deab954a537a90e9db1e0aeb6b10781fe100590537177c8010bf5d3efd86ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/34279989&rfr_iscdi=true